Cancer Crosslinks is an educational meeting series which promotes interactions between researchers and clinicians, and encourages translational and clinical research to support collaborations to advance the development of innovative cancer treatments.
Established in 2009 by Oslo Cancer Cluster in collaboration with its member, Bristol Myers Squibb, this yearly meeting has become a leading forum gathering oncologists, hematologists, translational researchers, healthcare providers, regulatory experts, and industry representatives.
The hallmark of Cancer Crosslinks is the educational program featuring international and Norwegian experts presenting recent advances in oncology. The educational program is complemented by tailored activities to stimulate additional interactions and discussions between speakers and representatives from the oncology community.
Cancer Crosslinks is an annual educational meeting which gathers prominent experts in oncology, providing a forum for networking and interaction.
Cancer Crosslinks 2021 partners are Bristol Myers Squibb & Merck.
WHY ATTEND CANCER CROSSLINKS?